OPRX
OptimizeRx Corp

1,128
Mkt Cap
$146.7M
Volume
973,828.00
52W High
$22.25
52W Low
$3.99
PE Ratio
-3,026.92
OPRX Fundamentals
Price
$7.53
Prev Close
$7.87
Open
$7.74
50D MA
$10.86
Beta
1.61
Avg. Volume
457,450.42
EPS (Annual)
-$1.10
P/B
1.20
Rev/Employee
$714,162.79
$108.72
Loading...
Loading...
Poll

Earnings Recap

• Reported GAAP EPS of $0.27 up 12.50% YoY • Reported revenue of $32.24M down -0.24% YoY • OptimizeRx is updating its fiscal year 2026 guidance, expecting revenue between $109M and $114M, with Adjusted EBITDA projected to be between $21M and $25M.

Bullish

OptimizeRx achieved strong full year revenue growth and adjusted EBITDA, met its "Rule of 40" benchmark, and authorized a $10M share repurchase program.

Bearish

OptimizeRx faces increased market volatility and customer caution due to MFN pricing, a decline in net revenue retention, and risks from customer concentration and evolving technology.

Latest OPRX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.